Author:
Richfield Edward,Marchant Rosie,Hole Barnaby
Publisher
Springer International Publishing
Reference106 articles.
1. Aronson JK. Polypharmacy, appropriate and inappropriate. Br J Gen Pract. 2006;56:484–5.
2. Aurobindo Pharma – Milpharm Ltd. Summary product characteristics. 2022. https://www.medicines.org.uk/emc/product/5206/smpc#gref. Accessed 31 May 2024.
3. Barrett MJ, Sargent L, Nawaz H, Weintraub D, Price ET, Willis AW. Antimuscarinic anticholinergic medications in Parkinson disease: to prescribe or Deprescribe? Mov Disord Clin Pract. 2021;8:1181–8. https://doi.org/10.1002/mdc3.13347.
4. Battistella M, Jandoc R, Ng JY, McArthur E, Garg AX. A province-wide, cross-sectional study of demographics and medication use of patients in hemodialysis units across Ontario. Can J Kidney Health Dis. 2018;5:205435811876083. https://doi.org/10.1177/2054358118760832.
5. Béreau M, Giffard M, Clairet A-L, Degenne G, Tatu L, Richfield E, et al. Terminal care in Parkinson’s disease: real-life use of continuous subcutaneous apomorphine infusion to improve patient comfort. J Parkinsons Dis. 2024;14:209–19. https://doi.org/10.3233/JPD-230201.